Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Union Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...

Today, India is the world’s largest producer of milk, pulses, and spices; the largest exporter of rice; and among the leading producers of ...

India and Oman's Comprehensive Economic Partnership Agreement, CEPA, begins on June 1. This pact offers Indian exports 100% duty-free acces...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Indian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

India's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...

Indian pharmaceutical exports are performing strongly. Shipments neared $29 billion by February this financial year. This growth continues ...

In May, Indian pharma companies enabled by their price competitiveness and good quality, made a global mark, with 60 per cent of the world'...

India's exports growth may slow to 15-17.5% in FY23 but containment of Covid-19 through massive vaccination across the globe and creation o...

The measures come in the wake of the country’s exports likely to take a hit in the months ahead as international buyers have started lookin...

Indian Pharma exports is on course to cross $23b for the first time this fiscal.

India had revenue of $ 665 million in this space which was expected to reach $ 800 million soon, said Steven H Myint.